Event Details

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

KemPharm Inc Annual Meeting of Stockholders

May 24, 2016 from 9:00 AM to 9:00 AM EDT


Harvard Club of New York City
Gordon Reading Room